Examining Neural Modulatory Effects of Serotonergic Psychedelic Compounds in Relation to Neuroticism
检查血清素迷幻化合物与神经质相关的神经调节作用
基本信息
- 批准号:10535571
- 负责人:
- 金额:$ 5.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-11-01 至 2023-07-26
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgonistAmygdaloid structureAnimal ModelAnimalsBindingBolus InfusionBrainBrain regionClipDSM-VDoseFellowshipFunctional Magnetic Resonance ImagingFutureGoalsHallucinogensHippocampus (Brain)HumanInfusion proceduresInterventionLinkLiteratureMagnetic Resonance ImagingMental HealthMental disordersMethodsModelingMolecularNeurobiologyNeuronal PlasticityNeurophysiology - biologic functionNeurotic DisordersOutcomePatient Self-ReportPatternPersonalityPersonality TraitsPersonality inventoriesPhysiologicalPositron-Emission TomographyPrefrontal CortexProcessPsychopathologyResearchResearch PersonnelRoleStressStructureSynapsesSynaptic plasticityTherapeutic EffectTimeblood oxygen level dependentdensityfirst-in-humanindexingmovienegative affectphysical conditioningpsychologicradioligandreceptorrelating to nervous systemtrait
项目摘要
PROJECT SUMMARY/ABSTRACT
Serotonergic 2A receptor agonists (“classic psychedelics”) have recently been described as
psychoplastogens in view of their selective modulatory effects on neural structure and function.
Although this neural modulatory mechanism has been well demonstrated in animal models,
researchers are only now examining its role in the living human brain. Understanding processes
involving selective and adaptive modulation of neural structure may in the future catalyze
important interventions into mental and physical health that harness the brain’s capacity for
plasticity. The present proposal leverages a comprehensive set of methods at molecular,
functional, and psychological levels of analysis to investigate whether and how psychedelic
compounds produce neural plasticity, and whether neural modulatory processes underlie post-
acute changes in functional activation and synchrony in regions related to the personality trait
neuroticism and adaptive post-acute effects on neuroticism found in the literature. The long-term
goal of this line of research is to understand processes underlying selective modulation of neural
structure and function. The overall objective is to ascertain whether psychedelic compounds
produce neural plasticity indexed by Positron Emission Tomography radioligand indices of
synaptic density and functional Magnetic Resonance Imaging activation and synchrony, and
whether these changes covary with adaptive changes in neuroticism.
项目总结/摘要
5-羟色胺能2A受体激动剂(“经典迷幻剂”)最近被描述为
Psychoplastogens,鉴于其对神经结构和功能的选择性调节作用。
虽然这种神经调节机制已经在动物模型中得到了很好的证明,
研究人员现在才开始研究它在人类大脑中的作用。理解过程
涉及神经结构的选择性和适应性调节,
重要的心理和身体健康干预措施,利用大脑的能力,
可塑性本提案利用了分子、
功能和心理层面的分析,以调查是否和如何迷幻
化合物产生神经可塑性,以及神经调节过程是否是后
与人格特质相关的区域的功能激活和同步性的急剧变化
神经质和适应后急性神经质的影响在文献中发现。长期
这一系列研究的目标是了解神经元选择性调制的潜在过程。
结构和功能。总体目标是确定迷幻化合物是否
产生由正电子发射断层扫描放射性配体指数指示的神经可塑性
突触密度和功能性磁共振成像激活和同步,以及
这些变化是否与神经质的适应性变化协变。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca.
- DOI:10.1038/s41598-023-36184-3
- 发表时间:2023-06-09
- 期刊:
- 影响因子:4.6
- 作者:
- 通讯作者:
Examining the Therapeutic Effect of Ceremonial Ayahuasca on Narcissistic Personality and Antagonistic Externalizing in Adults.
- DOI:10.1521/pedi.2023.37.2.131
- 发表时间:2023-04
- 期刊:
- 影响因子:2.3
- 作者:Weiss, Brandon;Sleep, Chelsea;Miller, Joshua D.;Campbell, W. Keith
- 通讯作者:Campbell, W. Keith
A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.
- DOI:10.1177/02698811231167848
- 发表时间:2023-07
- 期刊:
- 影响因子:4.1
- 作者:Weiss, Brandon;Erritzoe, David;Giribaldi, Bruna;Nutt, David J.;Carhart-Harris, Robin L.
- 通讯作者:Carhart-Harris, Robin L.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brandon Weiss其他文献
Brandon Weiss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)